Kappos, Ludwig http://orcid.org/0000-0003-4175-5509
Edan, Gilles
Freedman, Mark S.
Hartung, Hans-Peter
Montalbán, Xavier
Barkhof, Frederik
Koelbach, Ralf
MacManus, David G.
Wicklein, Eva-Maria
,
Funding for this research was provided by:
University of Basel
Article History
Received: 3 January 2024
Revised: 25 April 2024
Accepted: 29 April 2024
First Online: 10 May 2024
Declarations
:
: None.
: L Kappos received no personal compensation. His institutions (University Hospital Basel/Foundation Clinical Neuroimmunology and Neuroscience Basel) have received the following exclusively for research support: steering committee, advisory board and consultancy fees (AbbVie, Actelion, Auriga Vision AG, Bayer HealthCare, Biogen, Celgene, Dörries Frank-Molnia & Pohlman, Eli Lilly, EMD Serono, Genentech, Genzyme, Glaxo Smith Kline, Janssen, Merck, Minoryx, Novartis, Roche, Sanofi, Santhera, Senda Biosciences, Shionogi and Wellmera AG); speaker fees (Bristol Myers Squibb, Celgene, Janssen, Merck, Novartis, and Roche); support for educational activities (Biogen, Desitin, Novartis, Sanofi and Teva); license fees for Neurostatus products; and grants (European Union, Innosuisse, Novartis, Roche, Swiss MS Society and Swiss National Research Foundation). F Barkhof has received compensation for consultancy from Bayer, Biogen Idec, Merck, Novartis, Roche, Combinostics, and IXICO, and has received research support from the Dutch MS Research Foundation, NIHR biomedical research center at UCLH and the EU (FP7 and IMI). MS Freedman has received compensation from Alexion, Atara Biotherapeutics, Bayer HealthCare, Beigene, BMS/Celgene, EMD Inc./EMD Serono and Merck Serono, Hoffman La-Roche, Janssen (J&J), Novartis, Pendopharm, Sanofi-Genzyme for consulting services. He also participates in a Sanofi-Genzyme and EMD Serono-sponsored speakers bureaus. G Edan has received honoraria for consulting from Biogen, Merck, Novartis, Sanofi, Roche, and LFB, and has received personal compensation for serving on the BENEFIT scientific advisory board and for speaking from Bayer AG. His institution has also received research support from Novartis, Sanofi, Merck, Biogen, Roche, and Teva. H-P Hartung has received honoraria for consulting and speaking at symposia from Bayer AG, Biogen Idec, BMS Celgene, GeNeuro, Merck, Novartis, Roche, Sanofi, and TG Therapeutics, with approval by the rector of Heinrich-Heine University. X Montalbán has received speaking honoraria and travel expenses for participation in scientific meetings and has been a steering committee member of clinical trials or participated in advisory boards of clinical trials in the past years with Actelion, Bayer, Biogen, Celgene, Genzyme, Merck, Novartis, Roche, Sanofi-Genzyme, Teva Pharmaceutical, Excemed, MSIF and NMSS. R Koelbach is an employee of Ingress-Health HWM GmbH (a Cytel company) and was an employee of Parexel International GmbH at the time of this study. DG MacManus has nothing to disclose. EM Wicklein is a salaried employee of Bayer AG.